Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [1];  [2];  [1]
  1. Biochemical Engineering Institute, Saarland University, Campus A 1.5, D-66123 Saarbruecken (Germany)
  2. Pharmacelsus GmbH, Science Park 2, D-66123 Saarbruecken (Germany)

Efficient and accurate safety assessment of compounds is extremely important in the preclinical development of drugs especially when hepatotoxicty is in question. Multiparameter and time resolved assays are expected to greatly improve the prediction of toxicity by assessing complex mechanisms of toxicity. An integrated approach is presented in which Hep G2 cells and primary rat hepatocytes are compared in frequently used cytotoxicity assays for parent compound toxicity. The interassay variability was determined. The cytotoxicity assays were also compared with a reliable alternative time resolved respirometric assay. The set of training compounds consisted of well known hepatotoxins; amiodarone, carbamazepine, clozapine, diclofenac, tacrine, troglitazone and verapamil. The sensitivity of both cell systems in each tested assay was determined. Results show that careful selection of assay parameters and inclusion of a kinetic time resolved assay improves prediction for non-metabolism mediated toxicity using Hep G2 cells as indicated by a sensitivity ratio of 1. The drugs with EC{sub 50} values 100 {mu}M or lower were considered toxic. The difference in the sensitivity of the two cell systems to carbamazepine which causes toxicity via reactive metabolites emphasizes the importance of human cell based in-vitro assays. Using the described system, primary rat hepatocytes do not offer advantage over the Hep G2 cells in parent compound toxicity evaluation. Moreover, respiration method is non invasive, highly sensitive and allows following the time course of toxicity. Respiration assay could serve as early indicator of changes that subsequently lead to toxicity.

OSTI ID:
21272572
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Journal Issue: 2 Vol. 237; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2
Journal Article · Sun Nov 01 00:00:00 EDT 2009 · Toxicology and Applied Pharmacology · OSTI ID:21344772

Hepatocyte-based in vitro model for assessment of drug-induced cholestasis
Journal Article · Tue Dec 31 23:00:00 EST 2013 · Toxicology and Applied Pharmacology · OSTI ID:22285563

Species-specific toxicity of troglitazone on rats and human by gel entrapped hepatocytes
Journal Article · Sat Dec 31 23:00:00 EST 2011 · Toxicology and Applied Pharmacology · OSTI ID:22215194